- The #WeAreNotWaiting movement is hacking commercial insulin pumps and continuous glucose monitors to create open-source, closed-loop “artificial pancreas” systems; their flagship project is OpenAPS (openaps.org).  
- Participants argue FDA’s security requirements for approved devices make safe DIY experimentation difficult, while regulators have so far adopted a “we aren’t stopping you… yet” stance.  
- cluckj is preparing talking points for a U.S. senator on insulin pricing and FDA biosimilar policy, noting Novo Nordisk’s withdrawal of insulin from Greece and Germany after price-control attempts and bribery scandals in China.  
- kanzure proposes a reform in which FDA would be obliged to fund or facilitate alternative quality-of-life research for “walking-dead” patients when it blocks risky but potentially beneficial interventions.  
- Security concerns were raised about wireless-enabled medical devices being remotely hacked to harm users, with existing vulnerabilities already documented.  
- BioViva published early data claiming beneficial effects of a dual-gene therapy on blood biomarkers and muscle composition.  
- A pre-print (biorxiv.org/079806) links the neuronal receptor PTPσ (PTPRS) to Alzheimer’s disease pathogenesis.  
- kanzure collected and mirrored several Internet Archive census datasets and IRC log hashes for long-term integrity verification, and highlighted the “timmy” tool that uses TLS servers as ad-hoc trusted timestamping authorities.